Understanding the Subjective Experience of Long-term Remote Measurement Technology Use for Symptom Tracking in People With Depression: Multisite Longitudinal Qualitative Analysis.
depression
engagement
mental health
mobile phone
qualitative
remote measurement
technology
telehealth
Journal
JMIR human factors
ISSN: 2292-9495
Titre abrégé: JMIR Hum Factors
Pays: Canada
ID NLM: 101666561
Informations de publication
Date de publication:
26 Jan 2023
26 Jan 2023
Historique:
received:
13
05
2022
accepted:
07
11
2022
revised:
07
10
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
Remote measurement technologies (RMTs) have the potential to revolutionize major depressive disorder (MDD) disease management by offering the ability to assess, monitor, and predict symptom changes. However, the promise of RMT data depends heavily on sustained user engagement over extended periods. In this paper, we report a longitudinal qualitative study of the subjective experience of people with MDD engaging with RMTs to provide insight into system usability and user experience and to provide the basis for future promotion of RMT use in research and clinical practice. We aimed to understand the subjective experience of long-term engagement with RMTs using qualitative data collected in a longitudinal study of RMTs for monitoring MDD. The objectives were to explore the key themes associated with long-term RMT use and to identify recommendations for future system engagement. In this multisite, longitudinal qualitative research study, 124 semistructured interviews were conducted with 99 participants across the United Kingdom, Spain, and the Netherlands at 3-month, 12-month, and 24-month time points during a study exploring RMT use (the Remote Assessment of Disease and Relapse-Major Depressive Disorder study). Data were analyzed using thematic analysis, and interviews were audio recorded, transcribed, and coded in the native language, with the resulting quotes translated into English. There were 5 main themes regarding the subjective experience of long-term RMT use: research-related factors, the utility of RMTs for self-management, technology-related factors, clinical factors, and system amendments and additions. The subjective experience of long-term RMT use can be considered from 2 main perspectives: experiential factors (how participants construct their experience of engaging with RMTs) and system-related factors (direct engagement with the technologies). A set of recommendations based on these strands are proposed for both future research and the real-world implementation of RMTs into clinical practice. Future exploration of experiential engagement with RMTs will be key to the successful use of RMTs in clinical care.
Sections du résumé
BACKGROUND
BACKGROUND
Remote measurement technologies (RMTs) have the potential to revolutionize major depressive disorder (MDD) disease management by offering the ability to assess, monitor, and predict symptom changes. However, the promise of RMT data depends heavily on sustained user engagement over extended periods. In this paper, we report a longitudinal qualitative study of the subjective experience of people with MDD engaging with RMTs to provide insight into system usability and user experience and to provide the basis for future promotion of RMT use in research and clinical practice.
OBJECTIVE
OBJECTIVE
We aimed to understand the subjective experience of long-term engagement with RMTs using qualitative data collected in a longitudinal study of RMTs for monitoring MDD. The objectives were to explore the key themes associated with long-term RMT use and to identify recommendations for future system engagement.
METHODS
METHODS
In this multisite, longitudinal qualitative research study, 124 semistructured interviews were conducted with 99 participants across the United Kingdom, Spain, and the Netherlands at 3-month, 12-month, and 24-month time points during a study exploring RMT use (the Remote Assessment of Disease and Relapse-Major Depressive Disorder study). Data were analyzed using thematic analysis, and interviews were audio recorded, transcribed, and coded in the native language, with the resulting quotes translated into English.
RESULTS
RESULTS
There were 5 main themes regarding the subjective experience of long-term RMT use: research-related factors, the utility of RMTs for self-management, technology-related factors, clinical factors, and system amendments and additions.
CONCLUSIONS
CONCLUSIONS
The subjective experience of long-term RMT use can be considered from 2 main perspectives: experiential factors (how participants construct their experience of engaging with RMTs) and system-related factors (direct engagement with the technologies). A set of recommendations based on these strands are proposed for both future research and the real-world implementation of RMTs into clinical practice. Future exploration of experiential engagement with RMTs will be key to the successful use of RMTs in clinical care.
Identifiants
pubmed: 36701179
pii: v10i1e39479
doi: 10.2196/39479
pmc: PMC9945920
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e39479Informations de copyright
©Katie M White, Erin Dawe-Lane, Sara Siddi, Femke Lamers, Sara Simblett, Gemma Riquelme Alacid, Alina Ivan, Inez Myin-Germeys, Josep Maria Haro, Carolin Oetzmann, Priya Popat, Aki Rintala, Elena Rubio-Abadal, Til Wykes, Claire Henderson, Matthew Hotopf, Faith Matcham. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 26.01.2023.
Références
NPJ Digit Med. 2022 Jan 11;5(1):3
pubmed: 35017634
JMIR Ment Health. 2022 Aug 15;9(8):e38934
pubmed: 35969448
BMC Med. 2017 Dec 12;15(1):215
pubmed: 29228943
J Healthc Manag. 2010 Sep-Oct;55(5):353-64; discussion 364-5
pubmed: 21077584
BMC Med Res Methodol. 2013 Feb 06;13:14
pubmed: 23388075
Transl Behav Med. 2017 Jun;7(2):254-267
pubmed: 27966189
Eur J Ageing. 2010 Dec;7(4):313-316
pubmed: 21212820
Front Psychiatry. 2021 Jan 28;12:625247
pubmed: 33584388
Pharmacoeconomics. 2021 Jun;39(6):653-665
pubmed: 33950419
JMIR Mhealth Uhealth. 2019 Aug 01;7(8):e11734
pubmed: 31373275
J Affect Disord. 2022 Aug 1;310:106-115
pubmed: 35525507
J Clin Psychiatry. 2017 Jul;78(7):873-881
pubmed: 28858441
Gen Hosp Psychiatry. 2018 Mar - Apr;51:22-29
pubmed: 29272712
J Telemed Telecare. 2018 Feb;24(2):93-100
pubmed: 27831496
J Med Internet Res. 2021 Mar 24;23(3):e24387
pubmed: 33759801
JMIR Mhealth Uhealth. 2021 Jul 30;9(7):e29840
pubmed: 34328441
JMIR Mhealth Uhealth. 2021 Apr 12;9(4):e24604
pubmed: 33843591
NPJ Digit Med. 2022 Sep 3;5(1):133
pubmed: 36057688
JMIR Mhealth Uhealth. 2019 Jan 30;7(1):e11325
pubmed: 30698535
BMC Psychiatry. 2019 Feb 18;19(1):72
pubmed: 30777041
J Biomed Inform. 2019 Jan;89:29-40
pubmed: 30414474
BMC Psychiatry. 2021 Jan 29;21(1):65
pubmed: 33514333
Front Psychiatry. 2021 Jun 17;12:672347
pubmed: 34220580
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
NPJ Digit Med. 2020 Mar 3;3:27
pubmed: 32140569
NPJ Digit Med. 2022 Jun 29;5(1):82
pubmed: 35768544
JMIR Mhealth Uhealth. 2020 Jun 17;8(6):e17855
pubmed: 32554375
JMIR Ment Health. 2015 Mar 24;2(1):e8
pubmed: 26543914
J Drug Assess. 2019 May 24;8(1):97-103
pubmed: 31192030
J Affect Disord. 2016 Feb;191:88-93
pubmed: 26655117
J Med Internet Res. 2020 Jul 24;22(7):e17414
pubmed: 32706664
J Med Internet Res. 2018 Jul 12;20(7):e10480
pubmed: 30001997
BMC Psychiatry. 2022 Feb 21;22(1):136
pubmed: 35189842
J Med Internet Res. 2020 Jul 6;22(7):e16228
pubmed: 32628116
Clin J Pain. 2017 Aug;33(8):676-686
pubmed: 27898460